In addition to developing rare disease models, Protheragen also provides comprehensive [[ https://www.protheragen.us/solutions.html
| orphan disease research services ]] including drug safety evaluation, drug repurposing, artificial intelligence services, and therapeutic development solutions. As a CRO company long engaged in rare disease research, Protheragen has built a robust network of partnerships with academic institutions, pharmaceutical companies, and biotechnology firms to support this effort and improve research outcomes. |